Shaklee Acquires Selected Isagenix Assets as Direct Selling Consolidation Continues
A Shaklee subsidiary is buying selected assets from Isagenix, with business continuing unchanged during a transition period before integration into Shaklee's structure. The deal follows Shaklee's acquisition of a substantial part of Modere in May 2025 and adds another chapter to a long chain of consolidation in the channel.

A subsidiary deal with an open transition window
US-based Shaklee is acquiring selected assets from Isagenix through one of its subsidiaries, according to company communications. The transaction covers certain Isagenix assets rather than the business as a whole.
What follows the closing is a transition period. For now, the Isagenix business continues unchanged while preparations are made for later integration into the Shaklee structure. During this window, orders can still be placed, customers can be serviced and new members can be enrolled, with weekly payouts continuing for the time being under the existing Isagenix commission plan.
Key details remain undisclosed. Neither the purchase price nor the precise scope of the assets being taken over has been communicated, and the companies have not said what effects, if any, the deal may have on corporate structure or liabilities.
Products, platforms and plan: what changes and when
On the product side, the companies say the core Isagenix lines remain in place. The '30-Day Reset', the 'IsaLean Shakes' and the 'Collagen Elixir' are to be retained and will expand Shaklee's protein and dietary supplement range.
Isagenix Associates are, according to the plan, to gain access over time to Shaklee's broader wellness and beauty care assortment. The move into the Shaklee structure is described as gradual, built around a staged migration to Shaklee's platforms.
Associates who join Shaklee will in future operate under the Shaklee commission plan. Both companies have promised training, ongoing communication and support for the duration of the changeover.
Another step in a chain of consolidations
The transaction is not Shaklee's first move of this kind. In May 2025 the company already acquired a substantial part of Modere, whose products it has since sold through its own Ambassador network and via Shaklee.com.
Isagenix itself is the product of earlier consolidation. Zija International previously acquired Xango, and in 2020 Isagenix bought Zija.
Public figures for Isagenix are dated. Revenue in 2017 was reported at 958 million dollars, of which 700 million dollars was generated in the United States. In a statement relating to 2021, the company said it had reached close to 8 billion dollars in cumulative global revenue since its founding in 2002; no official numbers have been published since.
![[uk-house-ad] webinar4me banner 970Γ90](/_next/image?url=%2Fapi%2Fmedia%2Ffile%2Fuk-webinar4me-970x90.png&w=3840&q=75)
![[uk-house-ad] MLM System banner 970Γ90](/_next/image?url=%2Fapi%2Fmedia%2Ffile%2Fuk-mlmsystem-970x90.png&w=3840&q=75)

![[uk-house-ad] webinar4me banner 728Γ90](/_next/image?url=%2Fapi%2Fmedia%2Ffile%2Fuk-webinar4me-728x90.png&w=3840&q=75)
![[uk-house-ad] MLM System banner 728Γ90](/_next/image?url=%2Fapi%2Fmedia%2Ffile%2Fuk-mlmsystem-728x90.png&w=3840&q=75)

